CLINICAL_TRIALS
trial_result
· 2019-02-05
Clinical Trial Update: A Long-term Safety Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris [Phase 3]
Summary
A long-term safety study of olumacostat glasaretil gel in acne vulgaris completed Phase 3.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Dermira, Inc. | Conditions: Acne Vulgaris | Phase 3 | Status: COMPLETED | Results posted: 2019-02-05